Delivery Order SPE2DB24D1007-SPE2DB25FCBJX
- Not listed
- The Defense Logistics Agency awarded a $4,335.86 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a completion date of May 28, 2025. This competitively awarded contract utilizes firm fixed price pricing with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with a ceiling value of $1,566.65. The contract, awarded on April 22, 2025, with an ultimate completion date of April 23, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,451.66 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25–0.5 mg/dose pens in 3 ml quantities. The contract, which was competitively awarded without a set-aside designation, carries a firm fixed price and is scheduled for completion by December 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,266.60 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose) pens in 3ml quantities. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and was executed on July 14, 2025, with completion targeted for July 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,272.62 for Ozempic 0.25-0.5 mg/dose pens (3mL) on November 12, 2025, with an ultimate completion date of November 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,919.58 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on July 24, 2025, with a completion date of July 25, 2025. This competitive award was issued under a firm fixed-price contract type with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $17,574.08 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on September 9, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $8,339.25 to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3mL) with a firm fixed price structure. This non-competitive delivery order is scheduled for completion by December 31, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a $14,466.50 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract, which is not set aside for any specific category, represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The award was competitively awarded and will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,487.80 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) under a firm fixed-price contract. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-competitive set-aside delivery against the contractor's existing Indefinite Delivery Contract. The pharmaceutical products will be delivered to the company's corporate office location in...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCBJXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,483.62 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) under a firm fixed price contract. The award, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, medical supplies, and other pharmaceutical products to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements, including specialty medications and brand-name drugs, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 4/21/25 |